Drug intelligence / Profile preview

JinBi Granules

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

JinBi Granules is a Traditional Chinese Medicine (TCM) formulation developed by Longhua Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is designed for the treatment of chronic musculoskeletal conditions, specifically cervical spondylosis, lumbar disc herniation, and knee osteoarthritis. In TCM theory, these conditions are often categorized under "Bi syndrome," characterized by the obstruction of qi and blood in the meridians. The formulation is typically administered as "free fried granules" (mianjian keli), which are concentrated herbal extracts that do not require traditional decoction. Clinical trials have focused on evaluating its efficacy and safety in elderly patients suffering from degenerative bone and joint diseases, utilizing a "different diseases with the same therapy" research approach.

Brand names
JinBi Granules
Other names
JinBiJinBi mianjian keliFree fried granules of JinBi

Beyond the preview

Go deeper on JinBi Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JinBi Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call